Ticagrelor versus clopidogrel in acute coronary syndromes [1]

New England Journal of Medicine

Volumn 361, Issue 24, 2009, Pages 2385-2388

  Tomoda, Haruo ^a  

^a Tokyo Heart Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; TICAGRELOR; FIBRINOGEN RECEPTOR ANTAGONIST; ADENOSINE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PURINERGIC P2 RECEPTOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; BLEEDING; BRONCHOSPASM; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DEATH; DRUG METABOLISM; DRUG WITHDRAWAL; DYSPNEA; HEART ATRIOVENTRICULAR NODE; HEART INFARCTION; HUMAN; LETTER; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; STROKE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; LOADING DRUG DOSE; MORTALITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; RISK BENEFIT ANALYSIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; NOTE;

ACUTE CORONARY SYNDROME; ADENOSINE; DYSPNEA; HUMANS; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; TICLOPIDINE;

EID: 71849109776     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0909586     Document Type: Letter

References (4)

1. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057
2. Brown RA, Spina D, Page CP. Adenosine receptors and asthma. Br J Pharmacol 2008;153:Suppl 1:S446-S456.
3. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine: basic and clinical concepts. Circulation 1991;83:1499-1509
4. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002;105:1348-1353 (Pubitemid 34260427)